Rising instances of cancer, also referred to as malignant tumor or malignant neoplasm, has spawned a booming cancer diagnostic market worldwide..

1. HPV Testing Market - Global Industry Analysis, Size, Share,
Growth, Trends, And Forecast 2016 - 2024
Global HPV Testing Market: Overview
Rising instances of cancer, also referred to as malignant tumor or malignant neoplasm,
has spawned a booming cancer diagnostic market worldwide. This has filliped HPV
(Human Papilloma Virus) testing market, which is one of the most effective means of
detecting cancer, especially cervical cancer. HPV can cause cervical dysplasia and
cervical dysplasia, which in turn can result in cervical cancer. HPV can also lead to
rectal, oral, and penile cancer. Such HPV cancers can be thwarted with HPV vaccine.
However, almost half of women worldwide still refuse to take the life-saving three-
dose vaccine. Lack of awareness, especially in developing and underdeveloped
countries is one of the primary reasons behind it. But, there has been a few
developments for women, wanting a screening that is expected to propel the market in
the forthcoming years. An interim guidance released by the Society for Gynecologic
Oncology and American Society for Colposcopy and Cervical Pathology in 2015, said
HPV tests could replace Pap tests for women as young as 25.
Previous guidelines did not recommend the test for women under 30. Both tests study
cells gathered from the cervix. In a Pap test, those cells are examined under a
microscope for abnormalities. An HPV test looks for the presence of human
papillomavirus, particularly two types that are most likely to cause cancer. The use of
an HPV test in place of a Pap test, however, may take years to change the way
physicians screen for cervical cancer.
Global HPV Testing Market: Trends and Opportunities
Rising instances of cervical and vaginal cancer is one of the primary reasons driving
growth in the market. Cervical cancer is caused by sexually-transmissible genital
virus, known as HPV. In chronic HPV infections, the pre-malignant lesions or

2. abnormal cell growths that have been formed in the reproductive tract, grow into the
progressive, malignant form of cervical cancer. The HPV and Pap test help in early
detection of cervical cancer, which facilitates timely intervention at an early stage in
women.
As per CDC, 16 out of 100,000 women are expected to have cervical cancer every
year. It is the third-most commonly occurring cancer in women worldwide and claims
lives at an alarming rate.
This, along with technological breakthroughs brought about by prominent players in
the market have led to the growth in the market.
Global HPV Testing Market: Region-wise Outlook
North America has been the largest market in terms of revenue not just because of
increased cases of cervical cancer in the nation, but also because of rising awareness
among women resulting from government initiatives. In January 2016, for example,
UAB Comprehensive Cancer Centre, in collaboration with other cancer centers in the
U.S., carried out awareness programs about HPV vaccine that helps prevent many
forms of cancer. Liberal funding for research studies in this direction has also led to
breakthrough discoveries and innovations, which are expected to increase takers for
the HPV vaccine.
Sample Brochure Download:
Asia Pacific market is also predicted to expand rapidly in the forecast period owing to
high instances of communicable diseases in the developing economies such as India.
The increasing number of government awareness programs that promote the benefits
of early cancer screening is further expected to propel the market growth in the
coming years.
Companies Mentioned in the Research Report:
The prominent players in HPV testing are Abbott, AMDL, AdnaGen, Becton
Dickinson, Ambrilia Biopharma, Decode, Cepheid, Roche, Correlogic Systems,
Wallac, Dako, and Diadexus.
PDF Brochure

3. About Us
Transparency Market Research (TMR) is a global market intelligence company
providing business information reports and services. The company’s exclusive blend
of quantitative forecasting and trend analysis provides forward-looking insight for
thousands of decision makers. TMR’s experienced team of analysts, researchers, and
consultants use proprietary data sources and various tools and techniques to gather
and analyze information.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/